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Abstract
Background: Injurious mechanical ventilation (MV) may augment organ injury remote from the lungs. During
sepsis, myocardial dysfunction is common and increased endothelial activation and permeability can cause
myocardial edema, which may, among other factors, hamper myocardial function. We investigated the effects of
MV with injuriously high tidal volumes on the myocardium in an animal model of sepsis.
Methods: Normal rats and intraperitoneal (i.p.) lipopolysaccharide (LPS)-treated rats were ventilated with low (6 ml/
kg) and high (19 ml/kg) tidal volumes (Vt) under general anesthesia. Non-ventilated animals served as controls.
Mean arterial pressure (MAP), central venous pressure (CVP), cardiac output (CO) and pulmonary plateau pressure
(Pplat) were measured. Ex vivo myocardial function was measured in isolated Langendorff-perfused hearts. Cardiac
expression of endothelial vascular cell adhesion molecule (VCAM)-1 and edema were measured to evaluate
endothelial inflammation and leakage.
Results: MAP decreased after LPS-treatment and Vt-dependently, both independent of each other and with
interaction. MV Vt-dependently increased CVP and Pplat and decreased CO. LPS-induced peritonitis decreased
myocardial function ex vivo but MV attenuated systolic dysfunction Vt-dependently. Cardiac endothelial VCAM-1
expression was increased by LPS treatment independent of MV. Cardiac edema was lowered Vt-dependently by
MV, particularly after LPS, and correlated inversely with systolic myocardial function parameters ex vivo.
Conclusion: MV attenuated LPS-induced systolic myocardial dysfunction in a Vt-dependent manner. This was
associated with a reduction in cardiac edema following a lower transmural coronary venous outflow pressure
during LPS-induced coronary inflammation.
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Introduction
Septic patients often suffer from myocardial depression
and acute lung injury, therefore requiring circulatory
and ventilatory support [1]. The cause of the sepsis-
induced myocardial dysfunction is multifactorial (for
review see [2]) but endothelial activation is considered
to be an important pathogenic mechanism [3]. Upon
exposure to lipopolysaccharide (LPS) or tumor necrosis
factor (TNF)-a, endothelium becomes activated as
shown by expression of cell-adhesion molecules includ-
ing myocardial vascular cell adhesion molecule
(VCAM)-1 [4] immediately followed by an increase in
endothelial permeability [5,6]. Endothelial permeability
and subsequent leakage can cause myocardial edema,
which indeed was shown after LPS infusion [7] and can
hamper myocardial function [8].
Although the effect of mechanical ventilation (MV) on
hemodynamics is well described [9], its role on sepsis-
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Adverse effects of MV on myocardial contractility were
previously suggested [10]. Recently, it has been sug-
gested that alveolar injury caused by MV, also known as
ventilator-induced lung injury (VILI), can induce a syn-
drome similar to sepsis [11,12], by inducing the release
of inflammatory mediators from the lung. These media-
tors can increase microvascular permeability in lungs
and extrapulmonary organs, like the kidney and poten-
tially also in the heart, as a manifestation of remote
VILI-induced organ injury in the course of biotrauma
[12-14]. In line with this, exposure to perfusate from
injuriously ventilated lungs induced increased microvas-
cular permeability in uninjured lungs [15]. Also, a harm-
ful stimulus in the lung, such as LPS, may induce
pulmonary release of inflammatory mediators into the
circulation that can increase VCAM-1 expression on
liver vascular endothelial cells in vitro [16].
In this study we investigated the effect of MV with
normal and injuriously high tidal volumes (Vt) on myo-
cardial function during LPS-induced peritonitis. We
hypothesized that MV with high Vt during LPS-induced
peritonitis increases coronary VCAM-1 expression,
thereby increasing cardiac edema and deteriorating
myocardial function. Myocardial function was measured
ex vivo in isolated hearts as myocardial function in vivo
may be changed by differences in, amongst others, cor-
onary flow, heart rate and loading due to MV [9].
Methods
Animal preparation and measurements
All experiments applied with the Guide for Care and
Use for laboratory animals of the National Institute of
Health and were approved by the Institutional Animal
Care and Use Committee of the VU University Amster-
dam. Male Wistar rats weighing 300 ± 20 g were
anesthetized with 60 mg/kg pentobarbital (Nembutal,
CEVA Santa Animale BV, Maassluis, The Netherlands)
i.p. and 70 mg/kg ketamine (Alfasan, Woerden, The
Netherlands) i.m. Anesthesia was maintained with pen-
tobarbital (15 mg/kg) i.p. every 45 minutes and keta-
mine 20 mg/kg/h i.v. Paralysis was maintained with
pancuronium (Organon, Oss, The Netherlands) 0.6 mg/
kg/h i.v. to allow for high tidal volume mechanical ven-
tilation. Rats were placed in supine position on a heating
pad maintaining body temperature at 37°C. A tracheost-
omy was performed and a 14 Gauge canula was inserted
into the trachea. During preparation, rats were venti-
lated with a tidal volume (Vt) of 6 ml/kg and 5 cm H2O
positive end-expiratory pressure (PEEP) (Avea, CareFu-
sion, Houten, The Netherlands). Catheters were inserted
into the carotid artery and jugular vein for arterial blood
sampling and continuous measurement of the mean
arterial pressure (MAP) and central venous pressure
(CVP) in mmHg after calibration and zeroing to atmo-
spheric pressure. The femoral artery was catheterized
with a thermistor from a pulmonary artery catheter to
measure cardiac output (CO). CO was obtained every
30 minutes by averaging two successive thermodilution
determinations (CO Computer, 9520A, Edwards Labora-
tory, Santa Ana, Ca, USA), for which 200 μlo fc o l ds a l -
ine was injected via the right jugular vein catheter as
described previously [17]. Heart rate (HR) was measured
by continuous electrocardiography (Viridia CMS 2000,
Hewlett Packard, Boeblingen, Germany). Blood was
taken every hour for gas analysis and blood samples
were replaced by equal volumes of normal saline. Blood
gas analysis was performed using a pH blood-gas analy-
zer (ABL 50; Radiometer, Copenhagen, Denmark). Par-
tial pressure of arterial oxygen (PaO2, mmHg)/fraction
of inspired oxygen (FIO2) ratios were calculated. Plateau
pressure (Pplat) was taken from the ventilator.
Experimental protocol
After preparation, hemodynamics were allowed to stabi-
lize for 10 min after which base line values were estab-
lished. Rats were randomized to non-LPS treated or LPS
treated groups. The latter received LPS (7.5 mg/kg, LPS
L2880, LPS from E. Coli 055:B5, Sigma-Aldrich) through
an i.p. catheter. Five minutes after LPS infusion, the pro-
tocol was started and rats were randomly assigned to
one of two ventilation strategies; ventilation with either
low tidal volume (LTV; Vt 6 ml/kg, 5 cm H2O PEEP) or
high tidal volume (Vt 19 ml/kg, 5 cm H2O PEEP). Thus
four groups were studied; non-LPS treated (LTV-LPS, n
= 7) and LPS-treated rats (LTV + LPS, n = 8) ventilated
with low tidal volume and non-LPS treated (HTV-LPS,
n = 11) and LPS-treated rats (HTV + LPS, n = 8) venti-
lated with high tidal volume. The FIO2 was set at 0.4 in
both groups, ventilation rate was set to maintain normo-
c a p n i a .M A Pw a sm a i n t a i n e da tam i n i m u mo f6 0
mmHg by infusion of normal saline. Four hours after
the start of the protocol hearts were rapidly dissected
and mounted on an isolated Langendorff-perfused heart
setup as previously described [18], to study myocardial
function independent of loading condition.
Myocardial function ex vivo
Myocardial function was measured ex vivo,a si nt h i s
set-up it is possible to control loading, coronary pres-
sure and heart rate, and to measure coronary flow. Next
to the ventilated rats, non-ventilated rats, either non-
LPS treated (control-LPS) or LPS-treated (control +
LPS), were studied. The latter received LPS and were
anesthetized and sacrificed after four hours. The groups
contained 6 rats each, except for the control + LPS (n =
7) and HTV-LPS groups (n = 8). Briefly, the aorta of the
isolated heart was cannulated and the heart was
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constant coronary perfusion pressure of 80 mmHg at
37°C. The modified Krebs-Henseleit solution contained
(in mM) 118.5 NaCl, 4.7 KCl, 1.4 CaCl2.2(H2O), 25
NaHCO3,1 . 2M g C l 2,1 . 2K H 2PO4 and 11 glucose and
was equilibrated with 95% O2 and 5% CO2 at a pH of
7.4. Afferent coronary flow was measured with a flow
meter (Transonic Systems Europe B.V., Maastricht, the
Netherlands). Both right and left atria were removed
and hearts were paced at 5 Hz with electrodes. A cus-
tom-made balloon was inserted in the left ventricle to
measure isovolumic pressures with a catheter tip man-
ometer system [18] and the heart was allowed to stabi-
lize for 20 minutes. Ventricular volume at maximal
pressure development (Vmax) was determined and bal-
loons were adjusted to 85% of Vmax. Hearts were
allowed to stabilize for another 10 min. After stabiliza-
tion, myocardial function was measured by + dP/dtmax,
-dP/dtmin, systolic and diastolic pressure. Since measure-
ments were performed at a fixed heart rate and preload,
+dP/dtmax and -dP/dtmin can be regarded as indices of
contractility and relaxation, respectively [19]. Developed
pressure was calculated as left ventricular (LV) systolic
pressure minus LV diastolic pressure. Tau, the time
constant of relaxation was calculated by fitting pressure
values of the descending part of a twitch with the for-
mula a*(1-exp
t/tau) + c. Fitting was started at 50% of
developed pressure so that tau was calculated for late
relaxation. After the protocol, lasting about 55 minutes,
hearts were removed from the isolated Langendorff-per-
fused heart set-up, cut transversally in three sections,
frozen in liquid N2 and stored at -80°C.
Wet to dry weight ratios
Wet/dry ratios were used as a measure of edema. Imme-
diately after the rats were sacrificed, middle right lung
lob was taken and weighed, dried at 37°C and weighed
again. Apical section of the heart was used to calculate
cardiac wet/dry ratio. Frozen sections were weighed,
freeze-dried and weighed again.
VCAM-1 expression
Coronary VCAM-1 expression was determined by
immunofluorescence microscopy. Cardiac cryosections
(5 μm) were incubated with VCAM-1-antibody (1:40 sc-
1504-R Santa Cruz, Calif, USA) at room temperature for
1 hour followed by anti-rabbit secondary antibody stain-
ing and subsequent rhodamine-conjugated wheat germ
agglutinin (WGA for membranes, Molecular Probes
Europe, Leiden, The Netherlands) and DAPI nucleus
staining (Vectashield with DAPI, Vector Laboratories,
Burlingame, CA, USA). Image acquisition was per-
formed on a Zeiss Axiovert 200 M MarianasTM
inverted microscope. Microscopy was performed with a
10× objective. The microscope, camera, and data were
controlled by SlideBookTM software. In the images,
regions of interest (the vascular endothelium) were
selected by masking, previously described in detail [20].
Three masks were generated: the 1st by manually select-
ing the vasculature, the 2nd by automated selection of
FITC fluorescence above background, indicating VCAM
expression; and a 3 rd mask, which was the combination
of mask 1 and 2, indicating VCAM expression in the
vasculature. SlideBook™ software was used to determine
the mean fluorescence intensity of the 3 rd mask in
arbitrary units to indicate VCAM-1 expression. The sur-
face positive for VCAM-1 was calculated as percentage
of total vascular surface.
Lung histology
After removal of the heart, the upper lobe of the left
lung was isolated, 5% gelatin was instilled and lungs
were frozen in liquid N2 and stored at -80°C. Pulmonary
cryosections (5 μm) were cut, and gelatin was removed
in warmed ethanol with consecutive concentrations ran-
ging from 100-0%. HE-staining was performed. Per sec-
tion, 5 photographs (9.4 μm
2) were taken using a Leica
DMRB microscope (Wetzlar, Germany). Intra-alveolar
cells per photo were counted in a blinded fashion.
Statistical analysis
Parameters were tested for normal distribution using Kol-
mogorov-Smirnov test. To analyze the effects of LPS, Vt
and their interaction, non-parametric distributions were
normalized by log-transformation or ranking and general
estimated equations (GEE) were performed, taking
repeated measures over time in the same rats and baseline
values as covariates into account where appropriate. A sta-
tistically significant interaction implies that the effect of Vt
dose over time differs among the non-LPS and LPS-trea-
ted rats. To assess the relation between myocardial func-
tion parameters and cardiac wet/dry weight ratios, non-
normalized data were used and Spearman’s rho correlation
was calculated to correct for non-parametric distributions.
Data are shown as mean ± SEM or median for scatter plot
presentation. Exact P values are given if > 0.001. P < 0.05
was considered statistically significant.
Results
In vivo measurements
In vivo measurements are shown in Figure 1. Baseline
characteristics were similar between the groups. MAP
decreased in LPS-treated rats (P = 0.01) while CO and
CVP were maintained. HR increased in non-LPS treated
rats but not in LPS-treated rats (HR at t = -10 and t = 240;
224 ± 13 and 312 ± 14 beats/min versus 227 ± 12 and 267
± 17 beats/min in non-LPS treated and LPS-treated rats
respectively, both ventilation strategies taken together, P =
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and t = 240; 7.38 ± 0.02 and 7.38 ± 0.02 versus 7.36 ± 0.01
and 7.25 ± 0.01, in non-LPS treated and LPS-treated rats
respectively, both ventilation strategies taken together, P <
0.001), but had no effect on PaO2/FIO2 ratios. LPS-treated
rats received more fluids than non-LPS treated rats (0.17
± 0.07 mL in non-LPS treated rats versus 8.9 ± 1.4 in LPS-
treated rats, P < 0.001). LPS treatment did not affect Pplat.
Increased Vt decreased MAP (P < 0.001) and more so
after LPS treatment (P < 0.001 for interaction). Increased
Vt increased CVP (P = 0.001; no interaction with LPS)
and decreased CO (P = 0.004; no interaction with LPS).
HR and fluid administration were not affected by Vt dose
and no interaction with LPS was observed. Blood pH
decreased with increasing Vt (pH at t = -10 and t = 240
7.39 ± 0.10 and 7.33 ± 0.03 versus 7.36 ± 0.10 and 7.28 ±
0.02 in LTV and HTV ventilation respectively, non-LPS
treated and LPS-treated rats taken together, P = 0.003) but
no interaction with LPS was observed. PaO2/FIO2 ratios
were not affected by Vt dose or interaction with LPS. Pplat
increased with Vt (P < 0.001); no interaction with LPS was
observed.
Pulmonary injury
Pulmonary wet/dry ratios were increased after LPS
treatment (P = 0.027) and Vt dose dependently after
MV (P < 0.001). A synergistic effect on pulmonary wet/
dry ratios was observed (P = 0.018 for interaction, Fig-
ure 2a). Intra-alveolar cell count was increased upon
MV (P = 0.041) but was not affected by LPS and no
interaction was observed (Figure 2b).
Myocardial function ex vivo
Myocardial function data obtained ex vivo are shown in
Figure 3. LPS-treated rats had a decreased myocardial
function, as was shown by decreases in LV systolic pres-
sure, LV developed pressure and + dP/dtmax and
increases in tau (P = 0.001) and -dP/dtmin (P < 0.001).
Maximal coronary flow was reduced in LPS-treated rats
compared to non-LPS treated rats (P < 0.001), but not
affected by MV. MV Vt dose-dependently improved
myocardial contractile function, shown by increased LV
systolic pressure (P = 0.04, no interaction with LPS) and
+d P / d t max (P = 0.025; no interaction with LPS), but no
effect on relaxation parameters tau and -dP/dtmin were
observed. LV end-diastolic pressure, and LV end-diasto-
lic volume, estimated as Vmax were not affected by LPS,
Vt dose or their interaction (data not shown).
Cardiac VCAM-1 expression and wet/dry ratios
LPS-treated rats had increased expression (P = 0.001) of
coronary VCAM-1 and a greater percentage of
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Figure 1 In vivo measurements in the course of time (LPS = lipopolysaccharide; LTV = low tidal volume, HTV = high tidal volume).A .
Mean arterial pressure decreased by LPS treatment (P = 0.011). B. Central venous pressure increased by MV with high Vt (P = 0.001). C. Cardiac
output decreased by MV with high Vt (P = 0.004). D Plateau pressure increased by MV with high Vt (P < 0.001) E. PaO2/FIO2 ratios were similar in
the groups.
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Figure 3 Myocardial function ex vivo (LPS = lipopolysaccharide; LTV = low tidal volume, HTV = high tidal volume). A. Left ventricular
systolic pressure decreased by LPS treatment (P < 0.001) and increased Vt-dependently (P = 0.04). B. Left ventricular developed pressure
decreased by LPS treatment (P < 0.001). C. Left ventricular + dP/dtmax decreased after LPS treatment (P < 0.001) and increased Vt-dependently (P
= 0.025). D. Left ventricular time constant of relaxation tau increased after LPS treatment (P = 0.001.) E. Left ventricular - dP/dtmin increased after
LPS treatment (P < 0.001). F. Maximal coronary flow decreased after LPS treatment (P < 0.001).
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expression than in non-LPS treated rats: (non-LPS trea-
ted rats 7.1 ± 0.8%, LPS-treated rats 10.7 ± 1.0%, P =
0.01, Figure 4a-c). MV did not affect VCAM-1 expres-
sion and no interaction was observed. Cardiac wet/dry
ratios were similar between LPS treated and non-LPS
treated rats (Figure 4d), however cardiac wet/dry ratios
were decreased by increased Vt (P = 0.001) and this was
more prominent in LPS-treated rats (P = 0.029 for inter-
action). Correlations were found between cardiac wet/
dry ratios and LV developed pressure (r = -0.44, P =
0.006), LV systolic pressure (r = -0.46, P = 0.004), +dP/
dtmax (r = -0.36, P = 0.028), -dP/dtmin (r = 0.35, P =
0.034) and tau (r = 0.40, P = 0.023).
Discussion
In this study we hypothesized that MV with high Vt
during LPS-induced peritonitis increases coronary
VCAM-1 expression and cardiac edema and thereby
aggravates LPS-induced myocardial dysfunction. In con-
trast to our hypothesis, MV with high Vtin vivo was
associated with improved myocardial contractility ex
vivo.
We used a LPS-induced peritonitis model as this
model is reproducible [21] and targets, amongst others,
the endothelium [11]. Indeed, LPS-induced peritonitis
increased pulmonary vascular permeability, as suggested
by pulmonary edema. In addition, Vt was set at 19 ml/
kg to induce VILI, in accordance with the literature
[22,23]. MV induced a further Vt-dose dependent
increase in pulmonary edema and an increase in intra-
alveolar cell count, despite unaltered PaO2/FiO2 ratios
[22]. These characteristics of our model comply with
early indicators of VILI [11]. Furthermore, LPS treat-
ment decreased MAP and maintained CO and CVP
without an increased heart rate, which indicates LPS-
induced systemic vasodilatation and myocardial dysfunc-
tion, as cardiac work for a given preload decreased, and
is consistent with previous observations [1]. As MAP
decreased after LPS treatment, these rats received more
fluids but this was not associated with an increase in
cardiac edema. Finally, treatment with LPS characteristi-
cally reduced myocardial function ex vivo in line with
previous observations [21,24]
MV with increasing Vt decreased cardiac output in
vivo, however, it increased myocardial contractile func-
tion ex vivo as evidenced by an attenuated LPS-induced
decrease in LV systolic pressure and + dP/dtmax. Diasto-
lic function, measured as -dP/dtmin and tau, was not
affected by MV. As coronary flow ex vivo was not
affected by MV, the observed changes in myocardial
function ex vivo after MV are not due to flow differ-
ences. We observed correlations between LV contractile
and relaxation parameters and cardiac edema. As edema
can hamper myocardial function [8], these correlations
suggest that decreased cardiac edema was, at least in
part, responsible for better myocardial contractile func-
tion in rats treated with LPS and MV with high Vt com-
pared to rats treated with LPS and MV with low Vt.
Formation of edema depends on microvascular perme-
ability through endothelial activation, and hydrostatic
and osmotic pressure differences. VCAM-1 was chosen
as parameter for endothelial activation since its coronary
expression was shown to be upregulated 4 hours after
LPS treatment [6,24]. Our study confirmed this, but the
phenomenon was not affected by MV. The lack of effect
of MV on VCAM-1 expression indicates that it is unli-
kely that the difference in edema among the modes of
MV was caused by differences in microvascular perme-
ability but rather resulted from differences in filtration
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Figure 4 Cardiac VCAM-1 expression and edema. Immunofluorescent staining of VCAM-1 expression in A. non-LPS treated and B. LPS-treated
rats (Bar = 25 μm). VCAM-1 expression (green), membranes (WGA, red) and nuclei (DAPI, blue) are visible. C. Fluorescence intensity in arbitrary
units (A.U.) was increased after LPS treatment (P = 0.001). D Cardiac wet/dry ratio decreased Vt-dependently (P = 0.001) particularly after LPS
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onary venous pressure during MV with high Vt was
partly responsible for the decrease in edema, particularly
during increased permeability in LPS-treated rats.
Transmural pressure of the coronary veins, which is a
driving force for cardiac edema, can be estimated from
CVP-(mean airway pressure*pressure transmission).
CVP increased by 1 mmHg during MV with high Vt.
Mean airway pressure increased during high Vt ventila-
tion by about 3.7 mmHg (5 cm H2O) as mean airway
pressure depends on PEEP, which was similar between
the two ventilated groups and Pplat, which was higher
during MV with high Vt. Airway pressure transmission
is normally about 50%, but can decrease to 30% in dis-
eased lungs due to increased stiffness [25]. These pres-
sure differences result in a lower transmural pressure of
the coronary veins during MV with high Vt, even in the
case of a decreased airway pressure transmission, and
this may have partially prevented edema formation. In
any case, the hydrostatic and colloid osmotic pressure
forces in the Langendorff-perfused heart set up were
similar across groups, so that development of group dif-
ferences in determinants of cardiac edema formation ex
vivo can be excluded [26].
Although it is generally accepted that hydrostatic
edema affects diastolic function [27], a decrease in myo-
cardial edema after MV with high Vt did not attenuate
LPS-induced diastolic dysfunction in our study. Hence,
t h ed e c r e a s ei nd i a s t o l i cf u nction during LPS-induced
peritonitis was only partly caused by increased perme-
ability edema, thereby perhaps rendering diastolic func-
tion, in contrast to systolic function, relatively
insensitive to attenuation of edema during MV with
high Vt. In fact, most studies indicating edema-induced
diastolic dysfunction were performed in otherwise
healthy animals subjected to hydrostatic rather than
increased permeability cardiac edema formation [8,27].
Cardiac output in vivo decreased with increasing Vt.
In contrast, myocardial function ex vivo increased when
animals were ventilated with increasing Vt. As HR did
not change with increasing Vtin vivo and as myocardial
function ex vivo was measured independent of changes
in loading and, our data suggest that changes in cardiac
output with high Vtin vivo were most likely caused by
changes in loading conditions and not by changes in
myocardial contractile function. Moreover, Gurkan et al.
found increased inflammation in livers and kidneys but
not in hearts of mice after acid aspiration and ventila-
tion with high Vt [28]. Indeed, patients on MV often die
from multiple organ failure and renal dysfunction may
be more prevalent than cardiac dysfunction [12].
Limitations of our study include the absence of an
intervention to show a direct relation between less myo-
cardial edema and increased contractility in vivo.A tt h e
time the study was designed, a control group with injur-
ious ventilation but unchanged airway pressure was not
included. Moreover, in this study we measured myocar-
dial function ex vivo as this provides the opportunity to
measure function independent from differences in cor-
onary flow, heart rate, loading and endocrine control.
However, isolation of the heart from the whole animal
may also be considered as a limitation as this takes the
study further away from clinical relevance [29].
In conclusion, MV with high Vt lead to mild VILI but
did not induce or aggravate myocardial dysfunction
caused by LPS-induced peritonitis. Instead, LPS-induced
myocardial dysfunction was attenuated in a Vt-depen-
dent manner. Attenuation was most likely due to a
decrease in cardiac edema as a result of a fall in trans-
mural coronary venous pressure in face of increased
endothelial activation and permeability, associated with
coronary inflammation. This contrasts with the injurious
effect of VILI on other remote organs like the kidneys
[14].
Note
These results have been presented in parts at the
Annual congress of the European Society of Intensive
Care Medicine (ESICM) 2009
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